What causes a pruritic scalp with annular scaly plaques diffusely distributed, patchy hair loss, and tender occipital lymphadenopathy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tinea Capitis (Scalp Ringworm)

The constellation of itchy scalp, annular scaly lesions with diffuse distribution, patchy hair loss, and tender occipital lymphadenopathy is most consistent with tinea capitis—a dermatophyte fungal infection of the scalp and hair follicles. This presentation represents an inflammatory variant of tinea capitis, which requires prompt recognition and systemic antifungal treatment to prevent permanent scarring alopecia 1.

Clinical Reasoning

The triad of scale, lymphadenopathy, and alopecia are cardinal clinical signs that strongly predict tinea capitis and justify starting treatment even before mycological confirmation 1. Your patient's presentation specifically suggests:

  • Inflammatory tinea capitis: The diffuse pustular variant presents with patchy alopecia coexisting with scattered pustules or low-grade folliculitis, characteristically associated with painful regional lymphadenopathy 1
  • Annular pattern: While annular lesions can occur in multiple conditions 2, when combined with scalp involvement, scaling, hair loss, and occipital adenopathy, this points definitively toward dermatophyte infection

Causative Organisms

The specific organism matters for treatment selection:

  • Trichophyton species (T. tonsurans, T. violaceum, T. soudanense): Account for 50-90% of cases in the U.K., producing "black dot" alopecia with broken hair stubs and fine scale 1
  • Microsporum species (M. canis, M. audouinii): Produce "grey patch" tinea with fine scaling and patchy circular alopecia; zoophilic species typically demonstrate more intense inflammatory response 1

Diagnostic Approach

Obtain scalp scrapings, hair plucks, or brush samples immediately for KOH microscopy and fungal culture 1. Look for:

  • Scalpel scraping of scale and hair from affected areas
  • Plucked hairs from the periphery of lesions
  • Brush technique for improved sensitivity

However, do not delay treatment while awaiting culture results when the clinical presentation is this characteristic 1.

Treatment Algorithm

Immediate Management

Start oral antifungal therapy immediately based on local epidemiology 1:

For Trichophyton species (most likely in U.K./U.S.):

  • Terbinafine (preferred for shorter duration):
    • <20 kg: 62.5 mg daily for 2-4 weeks
    • 20-40 kg: 125 mg daily for 2-4 weeks
    • 40 kg: 250 mg daily for 2-4 weeks

For Microsporum species (if suspected or confirmed):

  • Griseofulvin (only licensed option for children in U.K.):
    • <50 kg: 15-20 mg/kg/day for 6-8 weeks
    • 50 kg: 1 g/day for 6-8 weeks

    • Take with fatty food to improve absorption

Adjunctive Measures

Add antifungal shampoo (ketoconazole 2%, selenium sulfide 1%, or povidone-iodine) to reduce spore transmission 1.

Critical Pitfalls to Avoid

  1. Do not use topical therapy alone—it will not achieve mycological cure 1
  2. Do not mistake this for bacterial abscess—kerion (severe inflammatory variant) is commonly misdiagnosed, leading to inappropriate antibiotic use 1
  3. Do not confuse treatment-related "id reaction" (pruritic papular eruption around ears) with drug allergy—this represents immune response to dying fungus and does not require stopping antifungals 1
  4. Terbinafine fails against Microsporum—it cannot reach scalp surface arthroconidia in prepubertal children due to lack of sebum/sweat excretion 1

Treatment Failure Protocol

If no clinical improvement after 4 weeks 1:

  1. First assess: compliance, drug absorption, reinfection
  2. If ongoing positive cultures with clinical improvement: continue current therapy 2-4 more weeks
  3. If no initial improvement: switch to second-line agent
    • Itraconazole: 5 mg/kg/day for 2-4 weeks (effective against both Trichophyton and Microsporum)
    • Or switch between terbinafine and griseofulvin based on culture results

Why This Matters for Outcomes

Untreated or inadequately treated tinea capitis can result in:

  • Permanent scarring alopecia (especially with kerion or favus variants)
  • Ongoing transmission to household contacts and classmates
  • Progression to severe inflammatory kerion requiring prolonged treatment

The presence of tender lymphadenopathy indicates significant inflammatory response, making prompt systemic treatment essential to prevent permanent hair loss 1.

References

Related Questions

What non‑streptococcal conditions can cause a sandpaper‑type rash?
What are the differential diagnoses for a hyperkeratotic, adherent, scaly plaque on the anterior tibia and a hyperpigmented, scaly, punched‑out plaque on the lateral malleolus?
How should I diagnose and manage a 24-year-old male with a one‑year history of an asymmetric, well‑demarcated, large circular plaque with raised scaly erythematous borders and central clearing on the abdomen and buttock region that has not responded to oral and topical antifungal therapy?
How should I evaluate and manage a 20-year-old female with a three-day history of reddish, raised linear papules on the right knee and left calf accompanied by a burning sensation?
What is the differential diagnosis for a female patient with no prior medical problems except a remote cholecystectomy who presents with unilateral itchy scaly plaques, including scattered scaly patches on the inner thigh and separate hyperkeratotic lesions on the same side?
In a healthy 30‑year‑old woman with a 4‑day history of productive cough with green sputum, fever up to 39 °C responsive to acetaminophen, clear rhinorrhea, sore throat, bilateral chest discomfort, nasal congestion, and a single episode of diarrhea, what is the appropriate symptomatic treatment and follow‑up plan?
In a 2-year-old child with purulent discharge from both eyes, is the conjunctivitis more likely viral or bacterial?
In a patient with congestive heart failure currently receiving furosemide 40 mg twice daily and sacubitril/valsartan, what additional guideline‑directed therapies should be added to improve blood pressure and pulmonary edema control?
What are the diagnostic criteria for cyclothymic disorder?
For a female patient with heart failure who is already taking carvedilol 12.5 mg twice daily, what medication adjustments are recommended to optimize her therapy?
Can diosmin be used in ulcerative colitis, and what is the recommended dosage and safety considerations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.